Arsenic contamination in water causes many diseases. Therefore, various biosorbent materials have been tested for their ability to remove the two inorganic arsenic species commonly found in water, namely, arsenite As(III) and arsenate As(V). The arsenic biosorption is influenced by the pH value of the aqueous phase, arsenic concentration, presence of competing ions, and arsenic speciation. The biosorption kinetics of As(III) and As(V) has been reported to be rapid, with more than 80 % biosorption occurring during the first hour, followed by a second step which may take up to several hours. The pseudo‐second‐order model provided the best fit, which corresponds to a chemisorption process. The Langmuir model indicated that most arsenic ions are adsorbed in monolayer form and removal is better for As(III) than for As(V).
Heavy metals, derived from industrial wastewater discharge, present a serious threat to human health and to natural water. Biosorption is regarded as a cost-effective biotechnology for the treatment of high volume and low concentration wastewaters containing heavy metal(s) in the order of 1 to 100 mg L−1. Among the biomaterials for heavy metal removal which have been researched during the past decades is the Streptomyces species, a by-product of an industrial antibiotic fermentation process. This paper describes the hazards posed by heavy metals effluents on the environment and use of various Streptomyces species to remove heavy metals from aqueous solution. Characterization of Streptomyces species, factors affecting biosorption, biosorption isotherms and biosorption kinetics is discussed. Graphical abstract
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.